This page provides Regulatory news filings submitted by issuers listed on the BSX. Please note the BSX is not responsible for the content, accuracy or completeness of announcements filed by issuers and disclaims all liability for any loss arising from reliance on information contained within issuer announcements.

Jazz Pharmaceuticals – Second Quarter 2023 Financial Results

 

Hamilton, Bermuda:  10 August 2023 – In a filing with the Bermuda Stock Exchange, Jazz Pharmaceuticals announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance. Click the link to view the full filing:

 

2023 Q2 Financial Results

 

 

 

# # # #

 

About BSX

The Bermuda Stock Exchange (BSX) is a fully electronic, vertically integrated international securities market headquartered in Bermuda and organised in 1971. BSX specialises in the listing and trading of capital market instruments such as equities, debt issues, funds, hedge funds, derivative warrants, and insurance linked securities. To learn more about BSX visit https://www.bsx.com and or contact info@bsx.com